GlassScriptPhysician profile
William J Berg
NPI 1225009749
$14,231.42
in general payments reported to CMS, 2019-2025
25 companies · $259 in 2025
The $259 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,650 · 2020: $6,065 · 2021: $476 · 2022: $364 · 2023: $852 · 2024: $565 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,676.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,675.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $10,803.97 | 2019-2024 | Eluvia, Avvigo Guidance System, Watchman Access System |
| Abbott Laboratories | $864.80 | 2019-2024 | Amplatzer Amulet, Xience Skypoint, Perclose Prostyle |
| Bard Peripheral Vascular, INC. | $663.54 | 2019-2023 | Lutonix Drug Coated Balloon |
| Medtronic, INC. | $471.54 | 2021-2025 | Onyx Frontier, Interstim, Micra |
| Biotronik INC. | $277.18 | 2021-2023 | Orsiro Mission, Pantera Leo |
| Shockwave Medical, INC | $238.17 | 2019-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Inari Medical, INC. | $137.57 | 2019 | |
| Philips North America LLC | $131.88 | 2021-2023 | |
| Edwards Lifesciences Corporation | $118.11 | 2020-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Reflow Medical INC | $107.86 | 2024 | |
| Angiodynamics, INC. | $82.29 | 2023 | Auryon Laser System 100-120 Vac |
| Medtronic Vascular, INC. | $67.41 | 2020 | |
| Novartis Pharmaceuticals Corporation | $56.01 | 2019-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.42 | 2019-2020 | |
| Teleflex LLC | $23.04 | 2023 | Turnpike |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $22.98 | 2019-2020 | |
| Cardiva Medical, INC. | $22.81 | 2022 | |
| Novo Nordisk INC | $22.50 | 2024 | Ozempic |
| Terumo Medical Corporation | $21.19 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $18.17 | 2019 | |
| Lilly USA, LLC | $16.14 | 2024 | Mounjaro, Zepbound |
| Biosense Webster, INC. | $15.39 | 2023 | Carto 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.16 | 2020 | |
| Amgen INC. | $11.29 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Berg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.